US 8778870
Modified factor IX polypeptides and uses thereof
granted A61KA61K38/4846A61K48/00
Quick answer
US patent 8778870 (Modified factor IX polypeptides and uses thereof) held by Catalyst Biosciences, Inc. expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Catalyst Biosciences, Inc.
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K38/4846, A61K48/00, A61P, A61P7/04